Cocrystal Applications in Drug Delivery

In 2015, the first pharmaceutical cocrystal was approved by the FDA. Since then, the number of cocrystals on the market and in the development pipeline has been slowly but steadily growing. It is now well established that cocrystals are a versatile new approach to oral drug formulation. This Reprint Book is a collection of articles that show the utility of pharmaceutical cocrystals and various aspects of cocrystal research: ΓÇó Cocrystals as a strategy to modify the physicochemical properties of a drug such as dissolution behaviour, tabletability, and melting point; ΓÇó Development of new coformers; ΓÇó Screening studies for multiple cocrystal forms; ΓÇó Cocrystals in nano-sized drug delivery.